E
E.J.M. Nieveen van Dijkum
Researcher at University of Amsterdam
Publications - 21
Citations - 619
E.J.M. Nieveen van Dijkum is an academic researcher from University of Amsterdam. The author has contributed to research in topics: Medicine & Survival rate. The author has an hindex of 9, co-authored 21 publications receiving 451 citations. Previous affiliations of E.J.M. Nieveen van Dijkum include Boston Children's Hospital.
Papers
More filters
Journal ArticleDOI
Intermediate and long-term adverse effects of radioiodine therapy for differentiated thyroid carcinoma--a systematic review
S.C. Clement,Robin P. Peeters,Cécile M. Ronckers,Thera P. Links,M.M. van den Heuvel-Eibrink,E.J.M. Nieveen van Dijkum,R.R. van Rijn,H. J. H. van der Pal,S.J.C.M.M. Neggers,Leontien C. M. Kremer,B. L. F. van Eck-Smit,H. M. van Santen +11 more
TL;DR: Treatment with I-131 for DTC may have significant adverse effects, which seem to be dose dependent, and these adverse effects of treatment must be balanced when choosing for I- 131 therapy in patients with DTC.
Journal ArticleDOI
Balancing the benefits and harms of thyroid cancer surveillance in survivors of Childhood, adolescent and young adult cancer: Recommendations from the international Late Effects of Childhood Cancer Guideline Harmonization Group in collaboration with the PanCareSurFup Consortium
Sarah C Clement,Sarah C Clement,Leontien C. M. Kremer,Frederik A. Verburg,Jill H. Simmons,M. Goldfarb,Robin P. Peeters,Erik K. Alexander,Edit Bardi,E. Brignardello,Louis S. Constine,Catherine A. Dinauer,Valentina Drozd,F. Felicetti,Eva Frey,A. Heinzel,M.M. van den Heuvel-Eibrink,S. A. Huang,Thera P. Links,Kerstin Lorenz,Renée L. Mulder,S.J.C.M.M. Neggers,E.J.M. Nieveen van Dijkum,Kevin C. Oeffinger,R.R. van Rijn,Scott A. Rivkees,Cécile M. Ronckers,Arthur B. Schneider,Roderick Skinner,J. D. Wasserman,T. Wynn,Melissa M. Hudson,Paul C. Nathan,H. M. van Santen +33 more
TL;DR: Of the two available surveillance strategies, thyroid ultrasound and neck palpation, neither was shown to be superior and the recommendations highlight the need for shared decision making regarding whether to undergo surveillance for DTC and in the choice of surveillance modality.
Journal ArticleDOI
Recurrence of Pancreatic Neuroendocrine Tumors and Survival Predicted by Ki67
Cansu Guney Genc,Massimo Falconi,Stefano Partelli,Francesca Muffatti,S. van Eeden,Claudio Doglioni,Heinz-Josef Klümpen,C.H.J. van Eijck,E.J.M. Nieveen van Dijkum +8 more
TL;DR: Patients at high risk for recurrence after curative resection of G1 or G2 panNET can be identified by a Ki67 rate higher than 5% and should be more closely monitored postoperatively to detect recurrence early and might benefit from adjuvant treatment.
Journal ArticleDOI
The standard diagnostic work-up and surgical treatment of pancreatic head tumours.
Journal ArticleDOI
Surgery for adrenocortical carcinoma in The Netherlands: analysis of the national cancer registry data
T. M. A. Kerkhofs,Rob H.A. Verhoeven,H. J. Bonjer,E.J.M. Nieveen van Dijkum,M. R. Vriens,de Jakob Vries,C.H.J. van Eijck,Bert A. Bonsing,L. V. Van de Poll-Franse,H. R. Haak +9 more
TL;DR: The results associate surgery in a DAN center with a survival benefit for patients with local or locally advanced ACC, and hypothesize that a multidisciplinary approach for these patients explains the observed survival benefit.